The results of the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) have been made available at the 2022 San Antonio Breast Cancer...

The results of the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) are going to be presented at the 2022 San Antonio Breast Cancer...

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with...

Immune Microenvironment, Homologous Recombination Deficiency, and Therapeutic Response to Neoadjuvant Chemotherapy in Triple-negative...